LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
PVLA
Palvella Therapeutics, Inc.
There isn't enough reported data to score PVLA yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
PVLA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
PVLA's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
PVLA PE Valuation
PVLA has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
PVLA Forward outlook
There aren't enough analyst estimates for PVLA to show an outlook.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the stronger earnings trend. Trailing diluted EPS is up 51% for LLY versus PVLA down 142%.
PVLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$12.97 | +$14.97 |
| Q2 2024 | -$19.58 | +$9.96 |
| Q1 2024 | -$12.82 | +$31.92 |
| Q4 2023 | -$23.27 | +$12.67 |
| Q3 2023 | -$27.94 | +$11.26 |
| Q2 2023 | -$29.54 | +$18.46 |
| Q1 2023 | -$44.74 | +$12.06 |
| Q4 2022 | -$35.94 | +$20.86 |
PVLA is still losing money, but far less than before: $5.50 per share over the past year, against $67.20 at its worst in mid-2021.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the stronger quarterly revenue trend. Revenue is up 39% for LLY versus down 100% for PVLA.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
PVLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2024 | $53K | -97% |
| Q4 2023 | $1.3M | -78% |
| Q3 2023 | $19.5M | +264% |
| Q2 2023 | $20.1M | +442% |
| Q1 2023 | $1.9M | -82% |
| Q4 2022 | $5.8M | -31% |
| Q3 2022 | $5.4M | +32% |
| Q2 2022 | $3.7M | +13% |
PVLA's revenue has slid since its 2023 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2024 | -10006% | -9205 points |
| Q4 2023 | -347% | -150 points |
| Q3 2023 | -60% | +166 points |
| Q2 2023 | 10% | +344 points |
| Q1 2023 | -801% | -733 points |
| Q4 2022 | -197% | -67 points |
| Q3 2022 | -227% | +242 points |
| Q2 2022 | -333% | +177 points |
PVLA's operating margin was −10006% last quarter, down 9204 points from the same quarter a year ago, near the bottom of its range since 2019.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over PVLA on cash generation, producing positive trailing cash flow while its opponent burns cash.
PVLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.4M | -$6.6M |
| Q2 2026 | -$12.8M | -$7.4M |
| Q1 2026 | -$10.9M | -$4.1M |
| Q4 2025 | -$4.9M | -$2.4M |
| Q3 2025 | -$7.9M | -5496% |
| Q2 2025 | -$5.4M | -$4M |
| Q1 2025 | -$6.8M | +$228K |
| Q4 2024 | -$2.5M | +$17.1M |
PVLA has burned cash in almost every quarter: −$43M over the past year, against −$23M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over PVLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
PVLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +175K shares |
| 1 year | +31% | +3.5M shares |
| 3 years | +1460% | +13.6M shares |
| 5 years | +1965% | +13.8M shares |
| Available history | +2196% | +13.9M shares |
PVLA has 15M diluted shares, up 31% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
PVLA Net Leverage
PVLA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
PVLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.2 | Neutral |
| Stochastic | 73.5 | Neutral |
PVLA's weekly RSI is 55 (neutral) and its Stochastic is 73 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
PVLA PE vs Healthcare Sector
PVLA has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
PVLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.3 | 8.4% above |
| 20 week MA | $146.0 | 4.9% above |
| 50 week MA | $124.4 | 23% above |
| 100 week MA | $81.0 | 89% above |
| 200 week MA | $56.7 | 170% above |
PVLA is in an uptrend: it's above all five of its weekly moving averages, and 170% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
PVLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $265.6 | $219.2 | -17% |
| 2021 | $219.2 | $293.6 | +34% |
| 2022 | $293.6 | $72.8 | -75% |
| 2023 | $72.8 | $14.6 | -80% |
| 2024 | $14.6 | $12.0 | -18% |
| 2025 | $12.0 | $103.4 | +761% |
| 2026 YTD | $103.4 | $153.2 | +48% |
PVLA has the edge over LLY on returns for 2026, with the stronger performance.